Cargando…
Circulating APRIL levels are correlated with advanced disease and prognosis in rectal cancer patients
We have previously shown that the tumor necrosis factor family member a proliferation-inducing ligand (APRIL) enhances intestinal tumor growth in various preclinical tumor models. Here, we have investigated whether APRIL serum levels at time of surgery predict survival in a large cohort of colorecta...
Autores principales: | Lascano, V, Hahne, M, Papon, L, Cameron, K, Röeder, C, Schafmayer, C, Driessen, L, van Eenennaam, H, Kalthoff, H, Medema, J P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520648/ https://www.ncbi.nlm.nih.gov/pubmed/25622308 http://dx.doi.org/10.1038/oncsis.2014.50 |
Ejemplares similares
-
Cytokeratin 20 positive circulating tumor cells are a marker for response after neoadjuvant chemoradiation but not for prognosis in patients with rectal cancer
por: Hinz, Sebastian, et al.
Publicado: (2015) -
Decreased Circulating Levels of APRIL: Questioning Its Role in Diabetes
por: Carvalho-Santos, Adriana, et al.
Publicado: (2015) -
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
por: Sclafani, Francesco, et al.
Publicado: (2018) -
To target or not to target APRIL in systemic lupus erythematosus: that is the question!
por: Morel, Jacques, et al.
Publicado: (2013) -
Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients – a prospective study
por: Hinz, Sebastian, et al.
Publicado: (2017)